vs
Side-by-side financial comparison of OCULAR THERAPEUTIX, INC (OCUL) and UNITED SECURITY BANCSHARES (UBFO). Click either name above to swap in a different company.
UNITED SECURITY BANCSHARES is the larger business by last-quarter revenue ($13.5M vs $13.3M, roughly 1.0× OCULAR THERAPEUTIX, INC). UNITED SECURITY BANCSHARES runs the higher net margin — 25.2% vs -488.0%, a 513.2% gap on every dollar of revenue. On growth, UNITED SECURITY BANCSHARES posted the faster year-over-year revenue change (13.6% vs -22.4%). UNITED SECURITY BANCSHARES produced more free cash flow last quarter ($19.8M vs $-57.1M). Over the past eight quarters, UNITED SECURITY BANCSHARES's revenue compounded faster (3.0% CAGR vs -5.3%).
Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.
United Security Bancshares is a bank holding company headquartered in Fresno, California. It operates 11 branches.
OCUL vs UBFO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.3M | $13.5M |
| Net Profit | $-64.7M | $3.4M |
| Gross Margin | 88.0% | — |
| Operating Margin | -526.5% | 31.5% |
| Net Margin | -488.0% | 25.2% |
| Revenue YoY | -22.4% | 13.6% |
| Net Profit YoY | -33.6% | 36.8% |
| EPS (diluted) | $-0.27 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.3M | $13.5M | ||
| Q3 25 | $14.5M | $14.0M | ||
| Q2 25 | $13.5M | $12.6M | ||
| Q1 25 | $10.7M | $13.7M | ||
| Q4 24 | $17.1M | $11.9M | ||
| Q3 24 | $15.4M | $13.8M | ||
| Q2 24 | $16.4M | $13.0M | ||
| Q1 24 | $14.8M | $12.8M |
| Q4 25 | $-64.7M | $3.4M | ||
| Q3 25 | $-69.4M | $4.0M | ||
| Q2 25 | $-67.8M | $2.2M | ||
| Q1 25 | $-64.1M | $2.7M | ||
| Q4 24 | $-48.4M | $2.5M | ||
| Q3 24 | $-36.5M | $3.8M | ||
| Q2 24 | $-43.8M | $4.3M | ||
| Q1 24 | $-64.8M | $4.2M |
| Q4 25 | 88.0% | — | ||
| Q3 25 | 87.8% | — | ||
| Q2 25 | 85.6% | — | ||
| Q1 25 | 88.2% | — | ||
| Q4 24 | 92.8% | — | ||
| Q3 24 | 89.9% | — | ||
| Q2 24 | 90.8% | — | ||
| Q1 24 | 91.0% | — |
| Q4 25 | -526.5% | 31.5% | ||
| Q3 25 | -472.3% | 40.3% | ||
| Q2 25 | -502.6% | 24.0% | ||
| Q1 25 | -597.5% | 27.5% | ||
| Q4 24 | -296.1% | 27.5% | ||
| Q3 24 | -298.2% | 37.1% | ||
| Q2 24 | -265.1% | 46.4% | ||
| Q1 24 | -214.0% | 45.9% |
| Q4 25 | -488.0% | 25.2% | ||
| Q3 25 | -477.3% | 28.7% | ||
| Q2 25 | -503.9% | 17.2% | ||
| Q1 25 | -598.7% | 19.6% | ||
| Q4 24 | -283.3% | 20.9% | ||
| Q3 24 | -236.6% | 27.7% | ||
| Q2 24 | -266.3% | 33.0% | ||
| Q1 24 | -438.9% | 32.6% |
| Q4 25 | $-0.27 | $0.18 | ||
| Q3 25 | $-0.38 | $0.23 | ||
| Q2 25 | $-0.39 | $0.13 | ||
| Q1 25 | $-0.38 | $0.16 | ||
| Q4 24 | $-0.25 | $0.14 | ||
| Q3 24 | $-0.22 | $0.22 | ||
| Q2 24 | $-0.26 | $0.25 | ||
| Q1 24 | $-0.49 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $737.1M | $264.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $654.3M | $139.7M |
| Total Assets | $808.1M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $737.1M | $264.2M | ||
| Q3 25 | $344.8M | $211.1M | ||
| Q2 25 | $391.1M | $199.5M | ||
| Q1 25 | $349.7M | $198.4M | ||
| Q4 24 | $392.1M | $216.9M | ||
| Q3 24 | $427.2M | $216.8M | ||
| Q2 24 | $459.7M | $166.3M | ||
| Q1 24 | $482.9M | $168.6M |
| Q4 25 | $654.3M | $139.7M | ||
| Q3 25 | $258.2M | $137.4M | ||
| Q2 25 | $305.9M | $134.3M | ||
| Q1 25 | $265.9M | $132.9M | ||
| Q4 24 | $315.3M | $130.4M | ||
| Q3 24 | $352.0M | $132.9M | ||
| Q2 24 | $377.7M | $127.3M | ||
| Q1 24 | $408.0M | $124.2M |
| Q4 25 | $808.1M | $1.2B | ||
| Q3 25 | $410.9M | $1.2B | ||
| Q2 25 | $451.3M | $1.2B | ||
| Q1 25 | $405.9M | $1.2B | ||
| Q4 24 | $457.9M | $1.2B | ||
| Q3 24 | $490.4M | $1.3B | ||
| Q2 24 | $517.1M | $1.2B | ||
| Q1 24 | $538.9M | $1.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-54.2M | $22.1M |
| Free Cash FlowOCF − Capex | $-57.1M | $19.8M |
| FCF MarginFCF / Revenue | -430.9% | 146.0% |
| Capex IntensityCapex / Revenue | 21.4% | 16.8% |
| Cash ConversionOCF / Net Profit | — | 6.46× |
| TTM Free Cash FlowTrailing 4 quarters | $-216.9M | $36.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-54.2M | $22.1M | ||
| Q3 25 | $-50.7M | $7.0M | ||
| Q2 25 | $-55.2M | $8.7M | ||
| Q1 25 | $-44.7M | $3.0M | ||
| Q4 24 | $-39.4M | $19.6M | ||
| Q3 24 | $-36.6M | $5.4M | ||
| Q2 24 | $-24.8M | $2.3M | ||
| Q1 24 | $-33.9M | $7.4M |
| Q4 25 | $-57.1M | $19.8M | ||
| Q3 25 | $-56.7M | $6.1M | ||
| Q2 25 | $-56.5M | $8.1M | ||
| Q1 25 | $-46.6M | $2.9M | ||
| Q4 24 | $-39.6M | $18.6M | ||
| Q3 24 | $-36.6M | $5.3M | ||
| Q2 24 | $-25.5M | $2.0M | ||
| Q1 24 | $-34.1M | $7.0M |
| Q4 25 | -430.9% | 146.0% | ||
| Q3 25 | -390.0% | 43.7% | ||
| Q2 25 | -419.7% | 64.3% | ||
| Q1 25 | -435.6% | 21.2% | ||
| Q4 24 | -232.0% | 156.0% | ||
| Q3 24 | -237.6% | 38.1% | ||
| Q2 24 | -155.4% | 15.5% | ||
| Q1 24 | -231.1% | 54.8% |
| Q4 25 | 21.4% | 16.8% | ||
| Q3 25 | 41.2% | 6.0% | ||
| Q2 25 | 9.3% | 4.6% | ||
| Q1 25 | 18.1% | 0.9% | ||
| Q4 24 | 1.2% | 8.7% | ||
| Q3 24 | 0.6% | 0.7% | ||
| Q2 24 | 4.5% | 2.2% | ||
| Q1 24 | 1.7% | 3.6% |
| Q4 25 | — | 6.46× | ||
| Q3 25 | — | 1.73× | ||
| Q2 25 | — | 4.01× | ||
| Q1 25 | — | 1.13× | ||
| Q4 24 | — | 7.87× | ||
| Q3 24 | — | 1.40× | ||
| Q2 24 | — | 0.54× | ||
| Q1 24 | — | 1.79× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
